{"id": "BuPwbcQAAAAJ", "citedby": 48956, "citedby5y": 10662, "hindex": 112, "hindex5y": 50, "i10index": 333, "i10index5y": 203, "coauthors": [{"id": "rGXhrWoAAAAJ", "name": "Gregory J. Gores", "affiliation": "Mayo Clinic"}, {"id": "jqAp8wgAAAAJ", "name": "Guy G Poirier", "affiliation": "Universit\u00e9 Laval"}, {"id": "PedG3PYAAAAJ", "name": "Anand Patel", "affiliation": "St. Jude Children's Research Hospital"}], "name": "Scott Kaufmann", "affiliation": "Professor of Pharmacology and Medicine, Mayo Clinic College of Medicine", "interests": ["Apoptosis", "Anti-cancer drugs"], "cites_per_year": {"1991": 138, "1992": 225, "1993": 188, "1994": 335, "1995": 519, "1996": 812, "1997": 1080, "1998": 1370, "1999": 1470, "2000": 1526, "2001": 1715, "2002": 2004, "2003": 2356, "2004": 2306, "2005": 2426, "2006": 2176, "2007": 2189, "2008": 2224, "2009": 1957, "2010": 1938, "2011": 2080, "2012": 2138, "2013": 2126, "2014": 2006, "2015": 1999, "2016": 2083, "2017": 1997, "2018": 1872, "2019": 1850, "2020": 831}, "publications": [{"bib": {"title": "Mammalian caspases: structure, activation, substrates, and functions during apoptosis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RJOyoaXV5v8C", "citedby": "3561"}, {"bib": {"title": "Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eAlLMO4JVmQC", "citedby": "2933"}, {"bib": {"title": "Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:isU91gLudPYC", "citedby": "2149"}, {"bib": {"title": "Induction of apoptosis by cancer chemotherapy", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:C33y2ycGS3YC", "citedby": "1433"}, {"bib": {"title": "Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AYInfyleIOsC", "citedby": "1232"}, {"bib": {"title": "PARP inhibition: PARP1 and beyond", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Wq2b2clWBLsC", "citedby": "1167"}, {"bib": {"title": "Programmed cell death: alive and well in the new millennium", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tHtfpZlB6tUC", "citedby": "815"}, {"bib": {"title": "Cathepsin B contributes to TNF-\u03b1\u2013mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qE4H1tSSYIIC", "citedby": "798"}, {"bib": {"title": "The current status of camptothecin analogues as antitumor agents", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:D_tqNUsBuKoC", "citedby": "728"}, {"bib": {"title": "Caspases and caspase inhibitors", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:L_l9e5I586QC", "citedby": "707"}, {"bib": {"title": "Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w-fwKiQwpQAC", "citedby": "667"}, {"bib": {"title": "The role of proteases during apoptosis.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SAZ1SQo2q1kC", "citedby": "663"}, {"bib": {"title": "Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in \u2026", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:T_ojBgVMvoEC", "citedby": "614"}, {"bib": {"title": "Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-6RzNnnwWf8C", "citedby": "613"}, {"bib": {"title": "Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MIg0yeAD4ggC", "citedby": "572"}, {"bib": {"title": "Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:A8cqit5AE6sC", "citedby": "564"}, {"bib": {"title": "Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:z6xuaG2dYH0C", "citedby": "556"}, {"bib": {"title": "Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZOYfmFL0FrgC", "citedby": "525"}, {"bib": {"title": "PICKLE is a CHD3 chromatin-remodeling factor that regulates the transition from embryonic to vegetative development in Arabidopsis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TewouNez5YAC", "citedby": "523"}, {"bib": {"title": "Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:__bU50VfleQC", "citedby": "440"}, {"bib": {"title": "Nonhomologous end joining drives poly (ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mel-f30kHHgC", "citedby": "386"}, {"bib": {"title": "Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NxmKEeNBbOMC", "citedby": "367"}, {"bib": {"title": "Cell death induced by topoisomerase-targeted drugs: more questions than answers", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:c1e4I3QdEKYC", "citedby": "366"}, {"bib": {"title": "Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:unp9ATQDT5gC", "citedby": "348"}, {"bib": {"title": "Assessment of aldehyde dehydrogenase in viable cells", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NMlhSUseqAsC", "citedby": "343"}, {"bib": {"title": "Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AzKEL7Gb_04C", "citedby": "341"}, {"bib": {"title": "A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:EsEWqaRxkBgC", "citedby": "339"}, {"bib": {"title": "A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zwpXiJ37cpgC", "citedby": "332"}, {"bib": {"title": "Alterations in the apoptotic machinery and their potential role in anticancer drug resistance", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:H_jBuBxbQIAC", "citedby": "323"}, {"bib": {"title": "Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CNPyR2KL9-0C", "citedby": "316"}, {"bib": {"title": "Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-yGd096yOn8C", "citedby": "296"}, {"bib": {"title": "Caspase\u20106 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JP7YXuLIOvAC", "citedby": "287"}, {"bib": {"title": "The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KWzIFqRkAKkC", "citedby": "273"}, {"bib": {"title": "The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZqE1mSdD_DYC", "citedby": "266"}, {"bib": {"title": "Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina", "year": "1981"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-uzm3Y7AvW0C", "citedby": "265"}, {"bib": {"title": "Apoptosis in cancer: cause and cure", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Zh0EY9V9P6UC", "citedby": "262"}, {"bib": {"title": "Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hvmnpdAuIbkC", "citedby": "259"}, {"bib": {"title": "Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8dzOF9BpDQoC", "citedby": "255"}, {"bib": {"title": "Poly (ADP-ribose) polymerase inhibitors: recent advances and future development", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Ej9njvOgR2oC", "citedby": "246"}, {"bib": {"title": "Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RuPIJ_LgqDgC", "citedby": "243"}, {"bib": {"title": "A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:s9ia6_kGH2AC", "citedby": "227"}, {"bib": {"title": "S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hGdtkIFZdKAC", "citedby": "227"}, {"bib": {"title": "Low\u2010dose, single\u2010agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BmWJbWwHJAwC", "citedby": "226"}, {"bib": {"title": "Activation of multiple interleukin-1\u03b2 converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4aZ_i-5WJEQC", "citedby": "226"}, {"bib": {"title": "Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nPT8s1NX_-sC", "citedby": "223"}, {"bib": {"title": "Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:G1UMdFYMoxkC", "citedby": "221"}, {"bib": {"title": "Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oPLKW5k6eA4C", "citedby": "218"}, {"bib": {"title": "Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells.", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RtRctb2lSbAC", "citedby": "217"}, {"bib": {"title": "In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SxCCDk4iOpsC", "citedby": "210"}, {"bib": {"title": "Failure of iniparib to inhibit poly (ADP-Ribose) polymerase in vitro", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lYAcb2jw7qUC", "citedby": "208"}, {"bib": {"title": "Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:YB4bud6kWLwC", "citedby": "204"}, {"bib": {"title": "Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BJrgspguQaEC", "citedby": "202"}, {"bib": {"title": "Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:t-hv7AR41mYC", "citedby": "200"}, {"bib": {"title": "Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non\u2013small-cell lung cancer", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:LGlY6t8CeOMC", "citedby": "199"}, {"bib": {"title": "Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:LK8CI43ZvvMC", "citedby": "196"}, {"bib": {"title": "Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with \u2026", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:YTuZlYwrTOUC", "citedby": "194"}, {"bib": {"title": "G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:iyewoVqAXLQC", "citedby": "188"}, {"bib": {"title": "The estrogen receptor CpG island is methylated in most hematopoietic neoplasms", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TaaCk18tZOkC", "citedby": "188"}, {"bib": {"title": "Severe graft-versus-host disease in a liver-transplant recipient", "year": "1988"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_AeoHAGD03cC", "citedby": "185"}, {"bib": {"title": "Characterization of the major polypeptides of the rat liver nuclear envelope.", "year": "1983"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hQUaER0FWQ4C", "citedby": "185"}, {"bib": {"title": "Chemotherapy-induced apoptosis", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:s85pQhAUCrAC", "citedby": "184"}, {"bib": {"title": "The erasable Western blot", "year": "1987"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:z8nqeaKD1nsC", "citedby": "181"}, {"bib": {"title": "Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zUl2_INMlC4C", "citedby": "180"}, {"bib": {"title": "Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes", "year": "1977"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:X0DADzN9RKwC", "citedby": "177"}, {"bib": {"title": "A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Ic1VZgkJnDsC", "citedby": "167"}, {"bib": {"title": "Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jtI9f0ekYq0C", "citedby": "164"}, {"bib": {"title": "Proteomic analysis of mantle-cell lymphoma by protein microarray", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QVtou7C4vgoC", "citedby": "162"}, {"bib": {"title": "BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:c59VksA5Vz4C", "citedby": "161"}, {"bib": {"title": "Caspases Mediate Tumor Necrosis Factor-\ue700\u2013Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pQTOvowfQioC", "citedby": "160"}, {"bib": {"title": "Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nqdriD65xNoC", "citedby": "160"}, {"bib": {"title": "Current status of clinical trials of farnesyltransferase inhibitors", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:37UQlXuwjP4C", "citedby": "155"}, {"bib": {"title": "Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sfnaS5RM6jYC", "citedby": "154"}, {"bib": {"title": "JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ji7lAbPyDbYC", "citedby": "154"}, {"bib": {"title": "Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:anDooRL1HQEC", "citedby": "154"}, {"bib": {"title": "Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eI34FqJmdUoC", "citedby": "150"}, {"bib": {"title": "Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ijdKiLOsEJMC", "citedby": "150"}, {"bib": {"title": "Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jmjb1lOE9QIC", "citedby": "150"}, {"bib": {"title": "Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:R22Rs3tN8aoC", "citedby": "143"}, {"bib": {"title": "Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yY3RG6sOEgwC", "citedby": "142"}, {"bib": {"title": "Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:dAp6zn-oMfAC", "citedby": "142"}, {"bib": {"title": "Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:c_xDhezhKKUC", "citedby": "142"}, {"bib": {"title": "Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:OzeSX8-yOCQC", "citedby": "138"}, {"bib": {"title": "HIC1 hypermethylation is a late event in hematopoietic neoplasms", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AZju0d2GQJ0C", "citedby": "138"}, {"bib": {"title": "A subset of non-histone nuclear proteins reversibly stabilized by the sulfhydryl cross-linking reagent tetrathionate: polypeptides of the internal nuclear matrix", "year": "1984"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:naSTrk-c4S8C", "citedby": "138"}, {"bib": {"title": "Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wLxue7F8ec0C", "citedby": "137"}, {"bib": {"title": "Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:2vr6o8x5NLkC", "citedby": "136"}, {"bib": {"title": "Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wSy_KLzO7YEC", "citedby": "135"}, {"bib": {"title": "Comparison of potential markers of farnesyltransferase inhibition", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JWITY9-sCbMC", "citedby": "135"}, {"bib": {"title": "Tumorgrafts as in vivo surrogates for women with ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:XAp-VaTZjjwC", "citedby": "134"}, {"bib": {"title": "Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly (ADP-ribose) polymerase and restores the NF-\u03baB signaling pathway", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BOlwja0KXvYC", "citedby": "134"}, {"bib": {"title": "Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Og1tA8FjbJAC", "citedby": "133"}, {"bib": {"title": "Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xm0LlTxljI0C", "citedby": "130"}, {"bib": {"title": "Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:m4fbC6XIj1kC", "citedby": "128"}, {"bib": {"title": "Retention of the human Rad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:m92CDrhVnKEC", "citedby": "126"}, {"bib": {"title": "Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sJPMR1oEGYQC", "citedby": "126"}, {"bib": {"title": "Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hNSvKAmkeYkC", "citedby": "124"}, {"bib": {"title": "Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gV6rEsy15s0C", "citedby": "123"}, {"bib": {"title": "Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DXE8ND7PrJAC", "citedby": "120"}, {"bib": {"title": "Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lg2tdxc6qMwC", "citedby": "120"}, {"bib": {"title": "Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4Yq6kJLCcecC", "citedby": "120"}, {"bib": {"title": "ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Y9VhQm-5nPIC", "citedby": "119"}, {"bib": {"title": "Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jlhcAiayVhoC", "citedby": "119"}, {"bib": {"title": "Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wUn16MOA3RoC", "citedby": "119"}, {"bib": {"title": "APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:J3LtWjKFLicC", "citedby": "118"}, {"bib": {"title": "MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis A MECHANISTIC BASIS FOR SORAFENIB (BAY 43-9006)-INDUCED TRAIL SENSITIZATION", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qmtmRrLr0tkC", "citedby": "118"}, {"bib": {"title": "Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:J6OZcwVsj5AC", "citedby": "116"}, {"bib": {"title": "Topoisomerase II levels during granulocytic maturation in vitro and in vivo", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:R-LXmdHK_14C", "citedby": "116"}, {"bib": {"title": "Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:q09DtPQ_434C", "citedby": "115"}, {"bib": {"title": "Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase \u2026", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1r-w4gtu6w8C", "citedby": "115"}, {"bib": {"title": "Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus.", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MnogvFdIBdwC", "citedby": "115"}, {"bib": {"title": "Flavopiridol binds to duplex DNA", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4e5Qn2KL_jwC", "citedby": "114"}, {"bib": {"title": "The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:N4u4nq0IxgcC", "citedby": "112"}, {"bib": {"title": "Is TRAIL hepatotoxic?", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pYKElYtJMmwC", "citedby": "112"}, {"bib": {"title": "The relationship of the nuclear matrix to cellular structure and function", "year": "1979"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9DLIHnF0jcYC", "citedby": "110"}, {"bib": {"title": "The elephant and the blind men: making sense of PARP inhibitors in homologous recombination deficient tumor cells", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:g8uWPOAv7ggC", "citedby": "106"}, {"bib": {"title": "Apoptosis and the response to anticancer therapy", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nPTYJWkExTIC", "citedby": "106"}, {"bib": {"title": "Comparison of Paclitaxel-, 5-Fluoro-2\u2032-deoxyuridine-, and Epidermal Growth Factor (EGF)-induced Apoptosis evidence for egf-induced anoikis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:n3vGvpFsckwC", "citedby": "105"}, {"bib": {"title": "Cyclophosphamide resistance in medulloblastoma", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ndLnGcHYRF0C", "citedby": "102"}, {"bib": {"title": "Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:M0leSnx2MbUC", "citedby": "99"}, {"bib": {"title": "Apoptosis-associated caspase activation assays", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cBPnxVikjH8C", "citedby": "98"}, {"bib": {"title": "Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PQEM9vzQD9gC", "citedby": "98"}, {"bib": {"title": "Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ymY9cBF3mdcC", "citedby": "95"}, {"bib": {"title": "COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:G36d5HCDkJYC", "citedby": "94"}, {"bib": {"title": "Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:I8rxH6phXEkC", "citedby": "94"}, {"bib": {"title": "Death receptor 5 signaling promotes hepatocyte lipoapoptosis", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:M_lZXyI38BkC", "citedby": "94"}, {"bib": {"title": "A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Vr2j17o0sqMC", "citedby": "94"}, {"bib": {"title": "Nucleolar distribution of proteins B23 and nucleolin in mouse preimplantation embryos as visualized by immunoelectron microscopy", "year": "1990"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:FsLZdJ3BAzkC", "citedby": "94"}, {"bib": {"title": "Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WwIwg2wKZ0QC", "citedby": "93"}, {"bib": {"title": "Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:aDl3D7KC1E4C", "citedby": "88"}, {"bib": {"title": "Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cNe27ouKFcQC", "citedby": "87"}, {"bib": {"title": "Decreased drug accumulation in a mitoxantrone\u2010resistant gastric carcinoma cell line in the absence of P\u2010glycoprotein", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:orDZ08hpP44C", "citedby": "87"}, {"bib": {"title": "Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_tF6a-HnqWAC", "citedby": "86"}, {"bib": {"title": "Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:6VlyvFCUEfcC", "citedby": "86"}, {"bib": {"title": "Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KS-xo-ZNxMsC", "citedby": "86"}, {"bib": {"title": "Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and-independent imatinib resistance", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:7H_jS4BsgvYC", "citedby": "85"}, {"bib": {"title": "RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Azgs6IHzeyYC", "citedby": "85"}, {"bib": {"title": "Apoptosis in the treatment of cancer: a promise kept?", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:x21FZCSn4ZoC", "citedby": "84"}, {"bib": {"title": "Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:I858iXPj1OkC", "citedby": "83"}, {"bib": {"title": "Characterization of Caspase Processing and Activation in HL-60 Cell Cytosol Under Cell-free Conditions NUCLEOTIDE REQUIREMENT AND INHIBITOR PROFILE", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:7Frjd3zlGBUC", "citedby": "82"}, {"bib": {"title": "Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QsKbpXNoaWkC", "citedby": "82"}, {"bib": {"title": "A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QoJ_w57xiyAC", "citedby": "81"}, {"bib": {"title": "Additional members of the rat liver lamin polypeptide family. Structural and immunological characterization.", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oTdOBqtIf_kC", "citedby": "80"}, {"bib": {"title": "Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WzTVkKNmPSkC", "citedby": "78"}, {"bib": {"title": "Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yTLRzDEmwhEC", "citedby": "78"}, {"bib": {"title": "BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sgsej9ZJWHMC", "citedby": "77"}, {"bib": {"title": "Enhanced killing of cancer cells by poly (ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:0sTkTiv_uMkC", "citedby": "77"}, {"bib": {"title": "Binding of the glucocorticoid receptor to the rat liver nuclear matrix. The role of disulfide bond formation.", "year": "1986"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:EaFouW7jFu4C", "citedby": "77"}, {"bib": {"title": "Genomic Mechanisms of p210BCR-ABL Signaling INDUCTION OF HEAT SHOCK PROTEIN 70 THROUGH THE GATA RESPONSE ELEMENT CONFERS RESISTANCE TO PACLITAXEL-INDUCED APOPTOSIS", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:bVQMTfhMCi4C", "citedby": "76"}, {"bib": {"title": "Phase I and pharmacokinetic study of flavopiridol followed by 1-\u03b2-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RMgMIBzvq-4C", "citedby": "75"}, {"bib": {"title": "A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:W2uZP3ddy8sC", "citedby": "75"}, {"bib": {"title": "Methods utilized in the study of apoptosis", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:In6cVmBjs0IC", "citedby": "75"}, {"bib": {"title": "Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:natZJ_-F0IUC", "citedby": "74"}, {"bib": {"title": "Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:u3T1itk59dMC", "citedby": "73"}, {"bib": {"title": "Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9NZAP19TdFAC", "citedby": "73"}, {"bib": {"title": "Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:L24QuVWYgZ0C", "citedby": "73"}, {"bib": {"title": "Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yeL6HyUMUGUC", "citedby": "73"}, {"bib": {"title": "Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rCNdntzdTkkC", "citedby": "72"}, {"bib": {"title": "Alteration of the nucleolar localization of poly (ADP-ribose) polymerase upon treatment with transcription inhibitors", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3_LpOwP6eMYC", "citedby": "71"}, {"bib": {"title": "Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777 \u2026", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tz746QTLzJkC", "citedby": "70"}, {"bib": {"title": "Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3A3nxV7CjKIC", "citedby": "70"}, {"bib": {"title": "Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Y0-TYkg6YM4C", "citedby": "70"}, {"bib": {"title": "Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Vno172sVVMwC", "citedby": "69"}, {"bib": {"title": "Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wyM6WWKXmoIC", "citedby": "68"}, {"bib": {"title": "Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rLGzs9wiiwIC", "citedby": "68"}, {"bib": {"title": "Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8VtEwCQfWZkC", "citedby": "67"}, {"bib": {"title": "Analysis of the internal nuclear matrix: oligomers of a 38 kD nucleolar polypeptide stabilized by disulfide bonds", "year": "1986"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:YPNY0knpFBYC", "citedby": "67"}, {"bib": {"title": "On the TRAIL of a new therapy for leukemia", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KTwcwpFFj4wC", "citedby": "66"}, {"bib": {"title": "Evaluation of Apaf-1 and procaspases-2,-3,-7,-8, and-9 as potential prognostic markers in acute leukemia", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TesyEGJKHF4C", "citedby": "66"}, {"bib": {"title": "Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:H7nrzBkawXsC", "citedby": "66"}, {"bib": {"title": "Detection of DNA cleavage in apoptotic cells.", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PlWzFYVEG4EC", "citedby": "65"}, {"bib": {"title": "CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lK9BDNCuzFgC", "citedby": "63"}, {"bib": {"title": "A cell cycle-dependent BRCA1\u2013UHRF1 cascade regulates DNA double-strand break repair pathway choice", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CCeGMaHljPEC", "citedby": "61"}, {"bib": {"title": "Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xGWFX6Gbr9MC", "citedby": "61"}, {"bib": {"title": "6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KI9T_ytC6pkC", "citedby": "61"}, {"bib": {"title": "Temporal changes in chromatin, intracellular calcium, and poly (ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ifOnle78iJkC", "citedby": "61"}, {"bib": {"title": "Elevated DNA polymerase \u03b1, DNA polymerase \u03b2, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:VRfTbSk87rEC", "citedby": "61"}, {"bib": {"title": "Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WWeOtg8bX_EC", "citedby": "60"}, {"bib": {"title": "Association of topoisomerase II with the hepatoma cell nuclear matrix: the role of intermolecular disulfide bond formation", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rOcdG6UcVlcC", "citedby": "60"}, {"bib": {"title": "Evaluation of the BH3-only protein Puma as a direct Bak activator", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:EBV337fEn3EC", "citedby": "59"}, {"bib": {"title": "Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:g_UdREhPGEoC", "citedby": "59"}, {"bib": {"title": "Association of poly (ADP-ribose) polymerase with the nuclear matrix: The role intermolecular disulfide bond formation, RNA retention, and cell type", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:aEW5N-EHWIMC", "citedby": "59"}, {"bib": {"title": "Reutilization of immunoblots after chemiluminescent detection", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lbI08cpqPnQC", "citedby": "57"}, {"bib": {"title": "Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:60iIaj97TE0C", "citedby": "56"}, {"bib": {"title": "Detection of Poly (ADP-Ribose) Polymerase and Its Apoptosis-Specific Fragment by a Nonisotopic Activity\u2013Western Blot Technique", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9shLKfS_uJEC", "citedby": "56"}, {"bib": {"title": "Distribution of nucleolar proteins B23 and nucleolin during mouse spermatogenesis", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:6ZzL7HXColQC", "citedby": "56"}, {"bib": {"title": "The nuclear matrix: current concepts and unanswered questions.", "year": "1986"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:U0iAMwwPxtsC", "citedby": "56"}, {"bib": {"title": "Somatic mosaic mutations in PPM1D and TP53 in the blood of women with ovarian carcinoma", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MNNNGtAgD4EC", "citedby": "55"}, {"bib": {"title": "Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vnF2_uLGgtgC", "citedby": "55"}, {"bib": {"title": "CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oqD4_j7ulsYC", "citedby": "53"}, {"bib": {"title": "Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of \u2026", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RXiHnyRawswC", "citedby": "53"}, {"bib": {"title": "Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:XDrR66g3YHsC", "citedby": "53"}, {"bib": {"title": "Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w2UhwfzvF0QC", "citedby": "52"}, {"bib": {"title": "Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial \u2026", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3lUAU8Oskd0C", "citedby": "52"}, {"bib": {"title": "Cancer: How does doxorubicin work?", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Oo1CbQkBAzEC", "citedby": "51"}, {"bib": {"title": "Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uUvzmPk0f8oC", "citedby": "51"}, {"bib": {"title": "A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:kUhpeDhEZMUC", "citedby": "51"}, {"bib": {"title": "Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eH23hyXCXa4C", "citedby": "50"}, {"bib": {"title": "Prime, shock, and kill: priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8gBurD7jEYQC", "citedby": "48"}, {"bib": {"title": "Poly (ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:e84hm74t-eoC", "citedby": "48"}, {"bib": {"title": "Rad9 protects cells from topoisomerase poison-induced cell death", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:q0uBw5dMOAkC", "citedby": "48"}, {"bib": {"title": "Differential activity of GSK-3 isoforms regulates NF-\u03ba B and TRAIL-or TNF \u03b1 induced apoptosis in pancreatic cancer cells", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:7VEv-pLvLSsC", "citedby": "47"}, {"bib": {"title": "Prospects for the use of ATR inhibitors to treat cancer", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:txeM2kYbVNMC", "citedby": "47"}, {"bib": {"title": "A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TGkaJS32XoUC", "citedby": "47"}, {"bib": {"title": "Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:E7VqQtBCVmcC", "citedby": "47"}, {"bib": {"title": "Evolution beyond Newton, Darwin and entailing law", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oE_QS-WwsdAC", "citedby": "46"}, {"bib": {"title": "Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic \u2026", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xyvS_IvSCKsC", "citedby": "46"}, {"bib": {"title": "Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vVJNg6_NJEsC", "citedby": "46"}, {"bib": {"title": "In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PuOEWVtPfzwC", "citedby": "45"}, {"bib": {"title": "Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hHIA4WEVY-EC", "citedby": "44"}, {"bib": {"title": "S-peptide epitope tagging for protein purification, expression monitoring, and localization in mammalian cells", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NtCmTCuxid4C", "citedby": "44"}, {"bib": {"title": "YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8rLWgkbgOXQC", "citedby": "43"}, {"bib": {"title": "Metabolic effects and kill of human T-cell leukemia by 5-deazaacyclotetrahydrofolate, a specific inhibitor of glycineamide ribonucleotide transformylase", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:h168fVGZblEC", "citedby": "43"}, {"bib": {"title": "Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:7XUxBq3GufIC", "citedby": "42"}, {"bib": {"title": "Bak conformational changes induced by ligand binding: insight into BH3 domain binding and Bak homo-oligomerization", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:l6Q3WhenKVUC", "citedby": "42"}, {"bib": {"title": "Caspase-7 gene disruption reveals an involvement of the enzyme during the early stages of apoptosis", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JH5k92_tO-AC", "citedby": "42"}, {"bib": {"title": "A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QaSi33NTfwYC", "citedby": "42"}, {"bib": {"title": "Expresssion of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:as0KMg8qHbkC", "citedby": "42"}, {"bib": {"title": "Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:G7txJ4jiatkC", "citedby": "41"}, {"bib": {"title": "Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rbGdIwl2e6cC", "citedby": "41"}, {"bib": {"title": "DNA methylation variants at HIF3A locus, B-vitamin intake, and long-term weight change: gene-diet interactions in two US cohorts", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3WNXLiBY60kC", "citedby": "40"}, {"bib": {"title": "Mcl-1 degradation during hepatocyte lipoapoptosis", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:X4-KO54GjGYC", "citedby": "40"}, {"bib": {"title": "BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BJtnxTr0fRcC", "citedby": "40"}, {"bib": {"title": "Apoptosis, pharmacological implications and therapeutic opportunities", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BAanoTsO0WEC", "citedby": "39"}, {"bib": {"title": "BRCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-w1eE4La9_EC", "citedby": "38"}, {"bib": {"title": "MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NXYAu82O0W8C", "citedby": "38"}, {"bib": {"title": "BCL2 family, mitochondrial apoptosis, and beyond", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cOfwuRB03ygC", "citedby": "37"}, {"bib": {"title": "High cell surface death receptor expression determines type I versus type II signaling", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yIeBiWEAh44C", "citedby": "37"}, {"bib": {"title": "Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid \u2026", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RfUwGJFMQ-0C", "citedby": "37"}, {"bib": {"title": "Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:d6JCS5z0ckYC", "citedby": "36"}, {"bib": {"title": "Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Kqc1aDSOPooC", "citedby": "36"}, {"bib": {"title": "Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:i_7YvbSbtFEC", "citedby": "36"}, {"bib": {"title": "Topoisomerase II and the response to antileukemic therapy", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sbeIDTyQOFgC", "citedby": "36"}, {"bib": {"title": "Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:idthP5jqfYAC", "citedby": "36"}, {"bib": {"title": "Camptothecin analogues: studies from the Johns Hopkins Oncology Center", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GYcXSSpN504C", "citedby": "36"}, {"bib": {"title": "Proteolytic cleavage during chemotherapy-induced apoptosis", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:v_tt_AnqfNMC", "citedby": "35"}, {"bib": {"title": "Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4n0clTBhZ78C", "citedby": "34"}, {"bib": {"title": "A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PVqtIyvKoSUC", "citedby": "34"}, {"bib": {"title": "Comparison of complication rates of Hickman\u00ae catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Nufq_to8ts0C", "citedby": "33"}, {"bib": {"title": "Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA-target gene interactions in acute myeloid leukemia", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WgvcDLhf7hwC", "citedby": "33"}, {"bib": {"title": "Nature communications", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WHBERAHVdrEC", "citedby": "33"}, {"bib": {"title": "Phase I and pharmacologic study of infusional topotecan and carboplatin in relapsed and refractory acute leukemia", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uAPFzskPt0AC", "citedby": "33"}, {"bib": {"title": "Tipifarnib (ZARNESTRA (TM)) in previously untreated poor-risk AML and MDS: Interim results of a phase 2 trial.", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SpPTWFSNUtQC", "citedby": "33"}, {"bib": {"title": "A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:R6EwkKsDylYC", "citedby": "32"}, {"bib": {"title": "4EBP1/c-MYC/PUMA and NF-\u03baB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BCdnXsLIVDwC", "citedby": "32"}, {"bib": {"title": "Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ujxm2eEBZHIC", "citedby": "32"}, {"bib": {"title": "The saintly side of Smac/DIABLO: giving anticancer drug-induced apoptosis a boost", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MDX3w3dAD3YC", "citedby": "32"}, {"bib": {"title": "In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:svGagg1hbZMC", "citedby": "31"}, {"bib": {"title": "TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GiYFt9mpioMC", "citedby": "31"}, {"bib": {"title": "Therapy\u2010related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hefNtdE4IMkC", "citedby": "31"}, {"bib": {"title": "A one-step method for protein estimation in biological samples: nitration of tyrosine in nitric acid", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:V_vSwabWVtYC", "citedby": "30"}, {"bib": {"title": "Olaparib and \u03b1-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pbQCAAeKvsAC", "citedby": "29"}, {"bib": {"title": "Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma \u2026", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gkldIfsazJcC", "citedby": "29"}, {"bib": {"title": "Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Vztgr1qGG8IC", "citedby": "29"}, {"bib": {"title": "Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DQNrXyjhriIC", "citedby": "29"}, {"bib": {"title": "Osteoblasts protect AML cells from SDF\u20101\u2010induced apoptosis", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zzCxg_vo7cAC", "citedby": "28"}, {"bib": {"title": "Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tBlTYpvFGQIC", "citedby": "28"}, {"bib": {"title": "Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qsWQJNntlusC", "citedby": "28"}, {"bib": {"title": "Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hrkNWuzUpWwC", "citedby": "27"}, {"bib": {"title": "Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oldoQiaHq2UC", "citedby": "27"}, {"bib": {"title": "Immunodetection of human topoisomerase I-DNA covalent complexes", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nU66GSXDKhoC", "citedby": "26"}, {"bib": {"title": "Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:u0Mu_IsstPMC", "citedby": "26"}, {"bib": {"title": "Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1EqfMoDn7-AC", "citedby": "26"}, {"bib": {"title": "Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oYLFIHfuHKwC", "citedby": "26"}, {"bib": {"title": "A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:j5aT6aphRxQC", "citedby": "26"}, {"bib": {"title": "Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ukw-9cB-YDkC", "citedby": "26"}, {"bib": {"title": "Binding of dexamethasone to rat liver nuclei in vivo and in vitro: evidence for two distinct binding sites", "year": "1984"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oursBaop5wYC", "citedby": "26"}, {"bib": {"title": "Topotecan in combination chemotherapy.", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:0ngZmJvimKcC", "citedby": "25"}, {"bib": {"title": "Expression of nuclear envelope lamins A and C in human myeloid leukemias", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:q1zXlPLtbUIC", "citedby": "25"}, {"bib": {"title": "A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:aNch6Af-aFkC", "citedby": "24"}, {"bib": {"title": "Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rqnDXT1GswoC", "citedby": "24"}, {"bib": {"title": "Anticancer therapy: boosting the bang of Bim", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:c1AJUTjuCtUC", "citedby": "24"}, {"bib": {"title": "Anti-tumor activity of mTOR inhibitor temsirolimus for relapsed mantle cell lymphoma: a phase II trial in the North Central Cancer Treatment Group", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:bXQfdp6S9ecC", "citedby": "24"}, {"bib": {"title": "Zarnestra (tm)(R115777) in previously untreated poor-risk AML and MDS: Preliminary results of a phase II trial", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SrKkpNFED5gC", "citedby": "24"}, {"bib": {"title": "Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivity", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qCpRzq7zkD8C", "citedby": "24"}, {"bib": {"title": "Effect of P-glycoprotein on flavopiridol sensitivity", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:X5YyAB84Iw4C", "citedby": "23"}, {"bib": {"title": "Erasure of Western blots after autoradiographic or chemiluminescent detection", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CMvovTBb2okC", "citedby": "23"}, {"bib": {"title": "Auxin-induced Rapid Degradation of Inhibitor of Caspase-activated DNase (ICAD) Induces Apoptotic DNA Fragmentation, Caspase Activation, and Cell Death A CELL SUICIDE MODULE", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5LPo_wSKItgC", "citedby": "22"}, {"bib": {"title": "Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Nw_I7GeUguwC", "citedby": "22"}, {"bib": {"title": "Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388\u2013granulocyte-macrophage colony-stimulating factor (GM \u2026", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DquSII9TDu4C", "citedby": "22"}, {"bib": {"title": "Immunoblot analysis and band depletion assays", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AFmTUeZ1pmEC", "citedby": "22"}, {"bib": {"title": "APOBEC3G expression correlates with T-cell infiltration and improved clinical outcomes in high-grade serous ovarian carcinoma", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jKT558fuBk8C", "citedby": "21"}, {"bib": {"title": "Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sJK75vZXtG0C", "citedby": "19"}, {"bib": {"title": "Adaphostin and other anticancer drugs quench the fluorescence of mitochondrial potential probes", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:17ZO-CJnx_8C", "citedby": "19"}, {"bib": {"title": "A phase II\" window\" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yJjnfzR0HrkC", "citedby": "19"}, {"bib": {"title": "Mitochondrial apoptosis and BH3 mimetics", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:S0CDQJw8Yr4C", "citedby": "18"}, {"bib": {"title": "Development of PARP inhibitors: an unfinished story", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:T8_be82Iz5gC", "citedby": "18"}, {"bib": {"title": "Protein Kinase C\u03b2 Modulates Ligand-induced Cell Surface Death Receptor Accumulation A MECHANISTIC BASIS FOR ENZASTAURIN-DEATH LIGAND SYNERGY", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8uzoZH4hB9AC", "citedby": "18"}, {"bib": {"title": "Increased phosphorylation rate of intermediate filaments during mitotic arrest", "year": "1981"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hfzGNhXhx5MC", "citedby": "18"}, {"bib": {"title": "Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DwFgw5hZUzMC", "citedby": "16"}, {"bib": {"title": "Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BW2nPTmhBn4C", "citedby": "16"}, {"bib": {"title": "Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qPeb-qHga9sC", "citedby": "16"}, {"bib": {"title": "Genetic analysis of the short splice variant of the inhibitor of caspase-activated DNase (ICAD-S) in chicken DT40 cells", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Tfl4UtY-dJUC", "citedby": "16"}, {"bib": {"title": "A Phase 2 Consortium (P2C) Trial of R115777 (Tipifarnib) in Myelofibrosis with Myeloid Metaplasia.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:d4tt_xEv1X8C", "citedby": "16"}, {"bib": {"title": "Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction Ara-C dose and \u2026", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cRMvf6lLvU8C", "citedby": "16"}, {"bib": {"title": "Histone deacetylase inhibitors interrupt HSP90\u2022 RASGRP1 and HSP90\u2022 CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CLhUwle04lcC", "citedby": "15"}, {"bib": {"title": "Loss of HSulf\u20101 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3BvdIg-l-ZAC", "citedby": "15"}, {"bib": {"title": "Isolation of a TRAIL antagonist from the serum of HIV-infected patients", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:kO05sadLmrgC", "citedby": "15"}, {"bib": {"title": "Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3MwzVuqRcA0C", "citedby": "15"}, {"bib": {"title": "Central role of FADD in apoptosis induction by the mitogen activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Gpwnp1kGG20C", "citedby": "15"}, {"bib": {"title": "Apoptosis in neurobiology", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:XtJa11BXPS4C", "citedby": "15"}, {"bib": {"title": "An alternative approach to the quantitation of glucocorticoid-receptor complexes in the nuclei of lymphoid cells", "year": "1982"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:inmFHauC9wsC", "citedby": "15"}, {"bib": {"title": "Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QYmifXMdJWgC", "citedby": "14"}, {"bib": {"title": "A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cB__R-XWw9UC", "citedby": "14"}, {"bib": {"title": "Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nWoA1JPTheMC", "citedby": "14"}, {"bib": {"title": "BRCA1 and RAD51C promoter hypermethylation confer sensitivity to the PARP inhibitor rucaparib in patients with relapsed, platinum-sensitive ovarian carcinoma in ARIEL2 Part 1", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-LHtoeeytlUC", "citedby": "13"}, {"bib": {"title": "ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BPS1z4jHU5cC", "citedby": "13"}, {"bib": {"title": "On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WIXB4To3Tx4C", "citedby": "13"}, {"bib": {"title": "Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9LpHyFPp1DQC", "citedby": "13"}, {"bib": {"title": "Factors Affecting Topotecan Sensitivity in Human Leukemia Samplesa", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3vbIHxFL9FgC", "citedby": "13"}, {"bib": {"title": "Addition of Etoposide to Initial Therapy of Adult Acute Lymphoblastic Leukemia: A Combined Clinicaland Laboratory Study", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ojlX30-wUrgC", "citedby": "13"}, {"bib": {"title": "Evidence that rodent epididymal sperm contain the Mr\u223c 94,000 glucocorticoid receptor but lack the Mr\u223c 90,000 heat shock protein", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ShjGdcaqzI0C", "citedby": "13"}, {"bib": {"title": "Evidence that rodent epididymal sperm contain the Mr approximately 94,000 glucocorticoid receptor but lack the Mr approximately 90,000 heat shock protein.", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:K4-iKlO5MD4C", "citedby": "13"}, {"bib": {"title": "A phase I clinical trial of the poly (ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ITz7TVZQ0sgC", "citedby": "12"}, {"bib": {"title": "Poly (ADP-Ribose) polymerase inhibitor hypersensitivity in aggressive myeloproliferative neoplasms", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Zbx7W2Xs4QsC", "citedby": "12"}, {"bib": {"title": "Histone deacetylase inhibitors target the leukemic microenvironment by enhancing a Nherf1-protein phosphatase 1\u03b1-TAZ signaling pathway in osteoblasts", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rpSJNIKeXWsC", "citedby": "12"}, {"bib": {"title": "215 Updated clinical and preliminary correlative results of ARIEL2, a phase 2 study to identify ovarian cancer patients likely to respond to rucaparib", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DIubQTN3OvUC", "citedby": "12"}, {"bib": {"title": "Characterization of a human carcinoma cell line selected for resistance to the farnesyl transferase inhibitor 4-(2-(4-(8-chloro-3, 10-dibromo-6, 11-dihydro-5H-benzo-(5, 6 \u2026", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wGzT3bKASkAC", "citedby": "12"}, {"bib": {"title": "A Phase 2 consortium (P2C) trial of R115777 (Zarnestra) in myelofibrosis with myeloid metaplasia: interim analysis of 18 patients", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rFyVMFCKTwsC", "citedby": "12"}, {"bib": {"title": "Flavopiridol (NSC 649890, L86-8275): a cytotoxic flavone that induces cell death in human lung carcinoma cells", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QI7uKX5mnFEC", "citedby": "12"}, {"bib": {"title": "Laboratory studies of the mechanism of the oxygen airglow", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wgKq3sYidysC", "citedby": "12"}, {"bib": {"title": "Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gmHTDCtJMcoC", "citedby": "11"}, {"bib": {"title": "Oral Tipifarnib (R115777) Has Single Agent Anti-Tumor Activity in Patients with Relapsed Aggressive Non-Hodgkin Lymphoma (NHL): Results of a Phase II Trial in the University of \u2026", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wuD5JclIwkYC", "citedby": "11"}, {"bib": {"title": "Anti-Tumor Activity of Single-Agent CCI-779 for Relapsed Mantle Cell Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wBLCggQE-ToC", "citedby": "11"}, {"bib": {"title": "Analysis of caspase activation during apoptosis", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:a2necdfpwlEC", "citedby": "11"}, {"bib": {"title": "Rocket photometry and the lower-thermospheric oxygen nightglow", "year": "1987"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WGv8Og3F3KgC", "citedby": "11"}, {"bib": {"title": "Measurement of BH3-only protein tolerance", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jMZTt8odoasC", "citedby": "10"}, {"bib": {"title": "Context-dependent antagonism between Akt inhibitors and topoisomerase poisons", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yZoBfgUKqwcC", "citedby": "10"}, {"bib": {"title": "Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:M0j1y4EgrScC", "citedby": "10"}, {"bib": {"title": "The intrinsic pathway of apoptosis", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NU-BerS4NX4C", "citedby": "10"}, {"bib": {"title": "Active Oral Regimen for Elderly Adults with Newly Diagnosed Acute Myelogenous Leukemia (AML): Phase I Trial of Oral Tipifarnib (T) Combined with Oral Etoposide (E) for Adults \u2026", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:S2WlVNSe3u4C", "citedby": "10"}, {"bib": {"title": "Imatinib spells BAD news for Bcr/abl-positive leukemias", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NtGNdKbuCngC", "citedby": "10"}, {"bib": {"title": "Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cSdaV2aYdYsC", "citedby": "10"}, {"bib": {"title": "DNA topoisomerases in chemotherapy.", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pUxgyZctzPYC", "citedby": "10"}, {"bib": {"title": "Apoptosis: an optimization approach", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eFf2swCANGcC", "citedby": "9"}, {"bib": {"title": "Apparent cleavage of poly (ADP-ribose) polymerase in non-apoptotic mouse LTA cells: an artifact of cross-reactive secondary antibody", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8RAEygVn5_EC", "citedby": "9"}, {"bib": {"title": "Tyrosine phosphorylation of mitochondrial creatine kinase 1 enhances a druggable tumor energy shuttle pathway", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Amrzk_ktLr0C", "citedby": "8"}, {"bib": {"title": "Targeting bacteria to improve cancer therapy", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:j8pvxH-kN2QC", "citedby": "8"}, {"bib": {"title": "A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:i91s68tWr-MC", "citedby": "8"}, {"bib": {"title": "Abstract CT008: Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast \u2026", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AubyX3KqGToC", "citedby": "7"}, {"bib": {"title": "Phase I study of the combination of CPT-11/5-FU and leucovorin", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:VnuxuLaQPLMC", "citedby": "7"}, {"bib": {"title": "Effect of v-rasH on sensitivity of NCI-H82 human small cell lung cancer cells to cisplatin, etoposide, and camptothecin", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:C-Rn0OCouf8C", "citedby": "7"}, {"bib": {"title": "Evaluation of 2, 6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl) hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated \u2026", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4QKQTXcH0q8C", "citedby": "7"}, {"bib": {"title": "Erasable Western blots", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:adHtZc2wMuEC", "citedby": "7"}, {"bib": {"title": "The molecular origin and taxonomy of mucinous ovarian carcinoma", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:LNjCCq68lIgC", "citedby": "6"}, {"bib": {"title": "53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AkvegQHRDQ8C", "citedby": "6"}, {"bib": {"title": "A phase II study of the farnesyltransferase inhibitor tipifarnib demonstrates anti-tumor activity in patients with relapsed and refractory lymphomas", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:N6_Y7JlWxwsC", "citedby": "6"}, {"bib": {"title": "Dual Inhibition of mTORC1/mTORC2 Induces Apoptosis of Mantle Cell Lymphoma by Preventing Rictor Mediated AKTS473 Phosphorylation by Potentiating AKT2 \u2026", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:AFXcoJnoRH0C", "citedby": "6"}, {"bib": {"title": "Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary \u2026", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:B2rIPIGFPLEC", "citedby": "6"}, {"bib": {"title": "Interactions of oxaliplatin with the topoisomerase I inhibitors topotecan and SN-38", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pRWBApOjXDcC", "citedby": "6"}, {"bib": {"title": "Henderson], Somerville C (1999) PICKLE is a CHD3 chromatin-remodeling factor that regulates the transition from embryonic to vegetative development in Arabidopsis"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uoeYKOKFegwC", "citedby": "6"}, {"bib": {"title": "Genes associated with bowel metastases in ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:VHM5RxzNINsC", "citedby": "5"}, {"bib": {"title": "A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4Wrxgq2JVp0C", "citedby": "5"}, {"bib": {"title": "Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5p9vMBpPSXYC", "citedby": "5"}, {"bib": {"title": "A randomized phase II trial of three novel regimens for relapsed/refractory acute myeloid leukemia (AML) demonstrates encouraging results with a flavopiridol-based regimen \u2026", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4oJvMfeQlr8C", "citedby": "5"}, {"bib": {"title": "Genetic and epigenetic defects in DNA repair lead to synthetic lethality of poly (ADP-ribose) polymerase (PARP) inhibitors in aggressive myeloproliferative disorders", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZysSsiWj_g4C", "citedby": "5"}, {"bib": {"title": "Dynamics of granzyme B-induced apoptosis: mathematical modeling", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QKtdBID3u5MC", "citedby": "5"}, {"bib": {"title": "A Phase 1 Trial of Daily Oral Green Tea Extract in Asymptomatic, Rai Stage 0\u2013II Patients with Chronic Lymphocytic Leukemia.", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zdX0sdgBH_kC", "citedby": "5"}, {"bib": {"title": "Inhibitory effect of pirfenidone on glioblastoma cell lines: implications for treatment of neurofibromatosis", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DwWRdx-KAo4C", "citedby": "5"}, {"bib": {"title": "Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CRzUtm-VnGAC", "citedby": "5"}, {"bib": {"title": "The farnesyltransferase inhibitor, R115777, has significant in vitro activity in myelofibrosis with myeloid metaplasia.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mVC4hKzE2FoC", "citedby": "5"}, {"bib": {"title": "Fine-structural cytochemical and immunocytochemical observations on nuclear bodies in the bovine 2-cell embryo", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hKjooKYXoHIC", "citedby": "5"}, {"bib": {"title": "The role of proteases in neuronal apoptosis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GJVTs2krol4C", "citedby": "5"}, {"bib": {"title": "Methods used to study protease activation during apoptosis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vxA22ZmNLkoC", "citedby": "5"}, {"bib": {"title": "Resistance to topoisomerase II poisons: Is the answer in the promoter?", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Nnq8S6OXqDYC", "citedby": "5"}, {"bib": {"title": "Topoisomerases in human leukemia", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Gb6Hms-Uo9kC", "citedby": "5"}, {"bib": {"title": "Reconstruction of a conic-section surface from autocollimator-based deflectometric profilometry", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Kv9jytqXTosC", "citedby": "4"}, {"bib": {"title": "Methods and materials for assessing responsiveness to PARP inhibitors and platinating agents", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RgznTc0nqo4C", "citedby": "4"}, {"bib": {"title": "Phase I dose-escalation study of SCH 900776 in combination with cytarabine (Ara-C) in patients with acute leukemia", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xii_ZKWM4-0C", "citedby": "4"}, {"bib": {"title": "Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_mQi-xiA4oYC", "citedby": "4"}, {"bib": {"title": "The Raf kinase Inhibitor BAY 43-9006 accelerates Mcl-1 degradation and regulates pro-apoptotic function", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MGPUR4WVBMEC", "citedby": "4"}, {"bib": {"title": "Apoptotic pathways in cancer progression and treatment", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NZNkWSpQBv0C", "citedby": "4"}, {"bib": {"title": "Farnesyltransferase inhibition: Use of surrogate markers.", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SWgZeABleR0C", "citedby": "4"}, {"bib": {"title": "Mechanism of synergy between oxaliplatin and the topoisomerase 1 inhibitor SN-38.", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WMtz-WDmgKQC", "citedby": "4"}, {"bib": {"title": "INHIBITION OF APOPTOSIS-A NOVEL MECHANISM OF RESISTANCE TO MULTIPLE CYTOTOXIC AGENTS IN ACUTE MYELOID-LEUKEMIA", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:htyGaKyDgHMC", "citedby": "4"}, {"bib": {"title": "BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Q_E8KsG3g9MC", "citedby": "3"}, {"bib": {"title": "Assessment of drug sensitivity in hematopoietic stem and progenitor cells from acute myelogenous leukemia and myelodysplastic syndrome ex vivo", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CC3C2HR4nz8C", "citedby": "3"}, {"bib": {"title": "Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tSVUDDkujAIC", "citedby": "3"}, {"bib": {"title": "Bim regulation miRrors microRNA 17\u223c 92 cluster expression in endothelial cells in vivo", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:U5uP8zs9lfgC", "citedby": "3"}, {"bib": {"title": "Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib in Previously Untreated Older Adults with AML and Baseline Presence of a Specific 2-Gene Expression Signature Ratio", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eAUscmXIlQ8C", "citedby": "3"}, {"bib": {"title": "Phase I trial of the oral poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888, V) combined wtih topoecan (T) and carboplatin (C) for adults with relapsed and \u2026", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:IT1MJ6E3JesC", "citedby": "3"}, {"bib": {"title": "A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TeJ9juy8vcMC", "citedby": "3"}, {"bib": {"title": "Insulin Receptor A and IGF-IR in AML: Response", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:urP0JZOBBUsC", "citedby": "3"}, {"bib": {"title": "A phase I study of lapatinib and topotecan in patients with solid tumors", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:It0W0vAlS5QC", "citedby": "3"}, {"bib": {"title": "HSulf-1 nucleic acids, polypeptides and methods of using", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ehoypfNsBj8C", "citedby": "3"}, {"bib": {"title": "Anti-tumor activity of low-dose single agent CCI-779 for relapsed mantle cell/Lymphoma: A phase II trial in the North Central Cancer Treatment Group.", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:2_BaaiyHPJIC", "citedby": "3"}, {"bib": {"title": "Final results of a phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:iKswqCX-FLkC", "citedby": "3"}, {"bib": {"title": "Effects of Adaphostin, a Novel Tyrphostin Inhibitor, in Diverse Models of Imatinib Mesylate Resistance.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xa5BkEQK8BgC", "citedby": "3"}, {"bib": {"title": "ATR-and DNA-PK-dependent phosphorylation of histone H2AX by replication-mediated DNA double-strand break induced by camptothecin", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:I9gX6wnfuA8C", "citedby": "3"}, {"bib": {"title": "The Nitric Acid Method for Protein Estimation in Biological Samples", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ufKn5pxu7C0C", "citedby": "3"}, {"bib": {"title": "Activation of cell death pathways", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oAywNP-vUhwC", "citedby": "3"}, {"bib": {"title": "Topoisomerase II as a target for anticancer chemotherapy.", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8p8iYwVyaVcC", "citedby": "3"}, {"bib": {"title": "Erasure of western blots after autoradiography or chemiluminescent detection", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_IsBomjs8bsC", "citedby": "3"}, {"bib": {"title": "Binding of insulin (INS) and epidermal growth factor (EGF) to 3T3-LI fibroblasts, a'preadipocyte'cell line", "year": "1977"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:IHkkN1K1AlAC", "citedby": "3"}, {"bib": {"title": "FAM111A protects replication forks from protein obstacles via its trypsin-like domain", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3jqAvCjcdfEC", "citedby": "2"}, {"bib": {"title": "Therapeutic options for mucinous ovarian carcinoma", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xckinRaLORAC", "citedby": "2"}, {"bib": {"title": "Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African \u2026", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:plAW456RD7MC", "citedby": "2"}, {"bib": {"title": "A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced \u2026", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-ZoC36zw86wC", "citedby": "2"}, {"bib": {"title": "Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:G887dSk7Sz8C", "citedby": "2"}, {"bib": {"title": "Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker \u03b3H2AX", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:C5mqfHIFIucC", "citedby": "2"}, {"bib": {"title": "Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WTQy_8Ay2UsC", "citedby": "2"}, {"bib": {"title": "Randomized phase II trial of timed sequential cytosine arabinoside with and without the CHK1 inhibitor MK-8876 in adults with relapsed and refractory acute myelogenous leukemia", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8JTMrWI6FdcC", "citedby": "2"}, {"bib": {"title": "A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Leukemias", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_9Xh93LWpsYC", "citedby": "2"}, {"bib": {"title": "Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:dFKc6_kCK1wC", "citedby": "2"}, {"bib": {"title": "A phase I trial of veliparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:j6V8Syvup0UC", "citedby": "2"}, {"bib": {"title": "Abstract PR05: In vivo antitumor activity of the PARP inhibitor niraparib (MK-4827) in homologous recombination deficient and proficient ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nOiSByfp82kC", "citedby": "2"}, {"bib": {"title": "Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vD2iS2Kej30C", "citedby": "2"}, {"bib": {"title": "Altered Apoptosis in AML", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Oo_WeVVXg5wC", "citedby": "2"}, {"bib": {"title": "Genetic analysis of apoptotic execution", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:v_xunPV0uK0C", "citedby": "2"}, {"bib": {"title": "Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cdwqcPQS8ssC", "citedby": "2"}, {"bib": {"title": "Anti-tumor activity of low-dose single agent CCI-779 for relapsed mantle celllLymphoma: a phase II trial in the North Central Cancer Treatment Group", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:LWqeokA2EBkC", "citedby": "2"}, {"bib": {"title": "Method of treating mantle cell lymphoma", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:6Zm5LS9gQ5UC", "citedby": "2"}, {"bib": {"title": "A combination of low dose thalidomide with prednisone in myelofibrosis with myeloid metaplasia.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uoRD4RTSUPoC", "citedby": "2"}, {"bib": {"title": "Reutilization of Western blots after chemiluminescent detection or autoradiography", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1xBWf43XMUgC", "citedby": "2"}, {"bib": {"title": "Clinical correlates of increased circulating myeloid and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:E8ajGqO0XoUC", "citedby": "2"}, {"bib": {"title": "Gleevec therapy in myelofibrosis with myeloid metaplasia (MMM).", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:2Q0AJrNhS-QC", "citedby": "2"}, {"bib": {"title": "Paclitaxel potentiates cisplatin neurotoxicity in dorsal root ganglion neurons", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:HqhvjgTjE9cC", "citedby": "2"}, {"bib": {"title": "BRIEF INTENSIVE THERAPY FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)-SUPERIORITY OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ybfzIt2tCtgC", "citedby": "2"}, {"bib": {"title": "Kaufman SH, Black A, Shaper JH, Busch H. Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus", "year": "1989"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:HoDPlbN_d1QC", "citedby": "2"}, {"bib": {"title": "CORRELATION OF LYMPHOBLAST GLUCOCORTICOID RECEPTOR (GR) NUMBER AND PATIENT (PT) CHARACTERISTICS IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)", "year": "1984"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GtqhT-R7ZnwC", "citedby": "2"}, {"bib": {"title": "STUDIES ON THE RAT LIVER NUCLEAR PROTEIN MATRIX AND NUCLEAR ENVELOPE.", "year": "1982"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:kQqwFFzsCTwC", "citedby": "2"}, {"bib": {"title": "Rare BRIP1 missense alleles confer risk for ovarian and breast cancer", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:P2d6BWbXU0IC", "citedby": "1"}, {"bib": {"title": "The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:OqYjx1B7R3oC", "citedby": "1"}, {"bib": {"title": "Doubling down on BRCA-mutated cancer", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jtOrAYjvdewC", "citedby": "1"}, {"bib": {"title": "D, L-Methadon erh\u00f6ht den zytotoxischen Effekt konventioneller Krebstherapien", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:M8meJADSprsC", "citedby": "1"}, {"bib": {"title": "Abstract AP28: BRCA1 and RAD51C promoter hypermethylation confer sensitivity to PARP inhibitors in patients with platinum sensitive ovarian carcinoma", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JavbeY_VQWIC", "citedby": "1"}, {"bib": {"title": "Abstract IS04: PARP inhibitor combinations for the treatment of ovarian cancer", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-qpA3cGbmHsC", "citedby": "1"}, {"bib": {"title": "Methods and materials for assessing enzyme-nucleic acid complexes", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gnsKu8c89wgC", "citedby": "1"}, {"bib": {"title": "CPX-351 (cytarabine: daunorubicin liposome for injection) anti-leukemia activity is potentiated by Chk1 inhibition", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:6IBXqrN-DEwC", "citedby": "1"}, {"bib": {"title": "216 Phase I study of panobinostat and fractionated stereotactic re-irradiation therapy (FSRT) for recurrent high grade gliomas", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w5CyTnyFq80C", "citedby": "1"}, {"bib": {"title": "Therapy-related acute promyelocytic leukemia (t-APL): Observations on APL pathogenesis.", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:fF_gHTpLxhAC", "citedby": "1"}, {"bib": {"title": "Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and \u2026", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5rMqqAh47xYC", "citedby": "1"}, {"bib": {"title": "Insulin Receptor A and IGF-IR in AML\u2013Response", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rzmi0EmCOGEC", "citedby": "1"}, {"bib": {"title": "Phase I Trial of Autologous Hematopoietic Stem Cell Transplantation with Escalating Doses of Topotecan Combined with Cyclophosphamide and Carboplatin in Patients with Relapsed \u2026", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:HKviVsUxM5wC", "citedby": "1"}, {"bib": {"title": "Reutilization of western blots after chemiluminescent or autoradiographic detection", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KqnX2w3egDsC", "citedby": "1"}, {"bib": {"title": "Cell division, growth and death-Editorial overview: The cellular trinity of division, growth and death", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:x2hKVfJWtf0C", "citedby": "1"}, {"bib": {"title": "Evaluation of the In Vitro Activity of the Multikinase Inhibitor BAY 43-9006 (Sorafenib) in Primary Cells from Patients with Myelofibrosis with Myeloid Metaplasia \u2026", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:VjBpw8Hezy4C", "citedby": "1"}, {"bib": {"title": "A phase II trial of CPT-11 in patients (pts) with advanced gastric or gastroesophageal (GE) junction adenocarcinoma (ADCA): A clinical and pharmacodynamic evaluation. A North \u2026", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5VjbC5aozO0C", "citedby": "1"}, {"bib": {"title": "Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hEXC_dOfxuUC", "citedby": "1"}, {"bib": {"title": "BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in \u2026", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oynPyU19kbsC", "citedby": "1"}, {"bib": {"title": "Sar of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one inhibitors of the IGF-1 receptor kinase with in vivo antitumor activity.", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:L7vk9XBBNxgC", "citedby": "1"}, {"bib": {"title": "Use of camptothecins in the treatment of leukemia and related disorders", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vjZqxyZ7hS4C", "citedby": "1"}, {"bib": {"title": "Adaphostin-Induced Apoptosis in CLL B-Cells Is Associated with Induction of Oxidative Stress and Exhibits Synergy with Fludarabine.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZZwcLRaXOV4C", "citedby": "1"}, {"bib": {"title": "Interleukin-6 (IL-6) increases myeloid cell leukemia-1 (MCL-1) via an Akt signaling pathway in cholangiocarcinoma: Therapeutic implications for Akt inhibitors.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Cvh0bltMcLgC", "citedby": "1"}, {"bib": {"title": "CCI-779 inhibits phosphorylation of ribosomal S6 (pS6) in mantle cell lymphoma.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DGzKIA18-3YC", "citedby": "1"}, {"bib": {"title": "Impaired neutrophil apoptosis in patients with myelofibrosis with myeloid metaplasia: Myeloproliferation or myelo-accumulation?", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cF7EPgIk0B4C", "citedby": "1"}, {"bib": {"title": "Targeting the apoptotic machinery as a potential antileukemic strategy", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wkm4DBaukwsC", "citedby": "1"}, {"bib": {"title": "Experimental Therapeutics, Preclinical Pharmacology-Synergy of the Protein Farnesyltransferase Inhibitor SCH66336 and Cisplatin in Human Cancer Cell Lines.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:h-xndbdg2koC", "citedby": "1"}, {"bib": {"title": "Acute leukemia in adults", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:e3CVSTJ63dQC", "citedby": "1"}, {"bib": {"title": "Gastrointestinal toxicity of idarubicin in the treatment of leukemia.", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:e0LTWoPxLYMC", "citedby": "1"}, {"bib": {"title": "Evaluation of the effect of AG957 (NSC 654705) on chronic myelogenous leukemia cells in vitro.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tgTmbKTkO1IC", "citedby": "1"}, {"bib": {"title": "Biochemical dissection of nuclear events in apoptosis", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:za7pDTvVV8kC", "citedby": "1"}, {"bib": {"title": "Long-term follow-up of intensive, ara-C-Based chemotherapy followed by bone marrow transplantation (BMT) for adult acute lymphocytic leukemia (ALL): Improved survival with \u2026", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:u_mOZUIutIEC", "citedby": "1"}, {"bib": {"title": "Proteolytic cleavage of poly (ADP-ribose) polymerase in human leukemia cells treated with etoposide and other cytotoxic agents", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:feST4K8J0scC", "citedby": "1"}, {"bib": {"title": "Glucocorticoid receptor (GR) level in paediatric leukemia cells", "year": "1982"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4E1Y8I9HL1wC", "citedby": "1"}, {"bib": {"title": "Elevated Cleavage of Axl Receptor Tyrosine Kinase by MMP-9 Correlates with Severity of Pulmonary Tuberculosis", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DTjSuSUbmXsC", "citedby": "0"}, {"bib": {"title": "Exploring the relationship between homologous recombination score and progression-free survival in BRCA wildtype ovarian carcinoma: Analysis of veliparib plus \u2026", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:aVq8r21TQD4C", "citedby": "0"}, {"bib": {"title": "Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor \u03b1", "year": "2020"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZYLUaBFA95QC", "citedby": "0"}, {"bib": {"title": "DNA Repair, Apoptotic Pathways, CDK Inhibitors", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mnAcAzq93VMC", "citedby": "0"}, {"bib": {"title": "Clinical Categorization of Chronic Myelomonocytic Leukemia into Proliferative and Dysplastic Subtypes Correlates with Distinct Genomic, Transcriptomic and Epigenomic Signatures", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pYRxIbzCxX0C", "citedby": "0"}, {"bib": {"title": "A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:dJ_BR67V0s4C", "citedby": "0"}, {"bib": {"title": "ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rCzfLUpcSPoC", "citedby": "0"}, {"bib": {"title": "A phase II study (NCI9775) of sapanisertib (MLN0128/TAK-228) in relapsed and/or refractory acute lymphoblastic leukemia (ALL): Interim analysis.", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:it4f3qIuXWYC", "citedby": "0"}, {"bib": {"title": "Methods of detecting apobec3 expression and predicting clinical outcomes", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Wqn_fehR_TUC", "citedby": "0"}, {"bib": {"title": "CONSTITUTIVE TOPOISOMERASE I-DNA COVALENT COMPLEXES IN ACUTE MYELOID LEUKEMIA AND IMPLICATIONS FOR THERAPEUTIC TARGETING.", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:O0MA3yP7Y3UC", "citedby": "0"}, {"bib": {"title": "RAS mutations drive proliferative chronic myelomonocytic leukemia via activation of a novel KMT2A-PLK1 axis", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pwA0zy_liR0C", "citedby": "0"}, {"bib": {"title": "Topoisomerases and cancer chemotherapy: recent advances and unanswered questions", "year": "2019"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:FwTEoIZreccC", "citedby": "0"}, {"bib": {"title": "Topoisomerase I-DNA Covalent Complexes in Myeloid Malignancies: A Potential Biomarker for Topoisomerase I Inhibitor Sensitivity", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tL5YfqkXb3gC", "citedby": "0"}, {"bib": {"title": "BRCA reversion mutations in circulating cell-free tumour DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma (HGOC)", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mo9XK3BEATIC", "citedby": "0"}, {"bib": {"title": "A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MSzX15-gZgkC", "citedby": "0"}, {"bib": {"title": "1001TiP A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gI9wzKcniAoC", "citedby": "0"}, {"bib": {"title": "A PHASE 1 TRIAL OF THE PARP INHIBITOR VELIPARIB IN COMBINATION WITH INTRAPERITONEAL FLOXURIDINE (FUDR) IN EPITHELIAL OVARIAN CANCER", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GdZ7R06HQM4C", "citedby": "0"}, {"bib": {"title": "Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PazO6pb-sMwC", "citedby": "0"}, {"bib": {"title": "Methods and materials for killing hiv infected cells", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:UY3hNwcQ290C", "citedby": "0"}, {"bib": {"title": "53BP1 as a predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eJD0kABLposC", "citedby": "0"}, {"bib": {"title": "KETAMINE AND KETAMINE METABOLITES AS NOVEL ESTROGEN RECEPTOR LIGANDS: INDUCTION OF CYP2A6, CYP2B6 AND AMPA RECEPTOR-GENOMIC LINKS TO SEX-DIFFERENCES IN KETAMINE RESPONSE.", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:XUAslYVNQLQC", "citedby": "0"}, {"bib": {"title": "Correction: Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker \u03b3H2AX", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RdUpO4xyVKMC", "citedby": "0"}, {"bib": {"title": "Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma", "year": "2018"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:beqBT5984LEC", "citedby": "0"}, {"bib": {"title": "Getting a GRP on histone deacetylase inhibitor selectivity", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:VBDT71xRUdcC", "citedby": "0"}, {"bib": {"title": "Histone deacetylase inhibitors interrupt HSP90 center dot RASGRP1 and HSP90 center dot CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cTy_cm4PQvYC", "citedby": "0"}, {"bib": {"title": "DNA repair protein expression and response of homologous recombination deficient ovarian cancer to the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in the ARIEL2 \u2026", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:HAmI6pRF5skC", "citedby": "0"}, {"bib": {"title": "BRCA1 and RAD51C Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma", "year": "2017"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nbnL2fqDbzcC", "citedby": "0"}, {"bib": {"title": "Mitochondrial apoptosis and BH3 mimetics [version 1; referees", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1YatL4jblGcC", "citedby": "0"}, {"bib": {"title": "Proc\u00e9d\u00e9s et mat\u00e9riaux pour d\u00e9truire des cellules infect\u00e9es par le vih", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rUnQDpM0TEQC", "citedby": "0"}, {"bib": {"title": "INVESTIGATING THE ROLE OF MTH1 INHIBITION IN THE TREATMENT OF OVARIAN CANCER", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xIusEVNJREcC", "citedby": "0"}, {"bib": {"title": "Polymerase kappa determines the sensitivity of MTH1 inhibitors to cisplatin-resistant cell", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lRPiJ3GhvscC", "citedby": "0"}, {"bib": {"title": "Manipulating osteoblast differentiation in order to inhibit protection of AML cells within the bone marrow", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:BFa5h04uPMwC", "citedby": "0"}, {"bib": {"title": "Abstract B50: Antineoplastic activity of Top I inhibitor etirinotecan pegol (NKTR-102) and PARP inhibitor rucaparib (CO-388) in platinum-resistant high-grade serous BRCA WT \u2026", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:r56sNq9gaawC", "citedby": "0"}, {"bib": {"title": "Abstract B71: Old age and chemotherapy contribute to the selection of PPM1D somatic mosaic mutations in ovarian cancer.", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:e9bUPLv0EjcC", "citedby": "0"}, {"bib": {"title": "Antineoplastic activity of Top I inhibitor etirinotecan pegol (NKTR-102) and PARP inhibitor rucaparib (CO-388) in platinum-resistant high-grade serous BRCA WT ovarian cancer PDX", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1_W9tMSvGuwC", "citedby": "0"}, {"bib": {"title": "Homologous recombination mutations and overall survival in high-grade serous, endometrioid, and clear cell ovarian carcinomas", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cww_0JKUTDwC", "citedby": "0"}, {"bib": {"title": "Abstract A07: Homologous recombination mutations and overall survival in high-grade serous, endometrioid, and clear cell ovarian carcinomas.", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KIRwYnRZzWQC", "citedby": "0"}, {"bib": {"title": "Mitochondrial apoptosis and BH3 mimetics", "year": "2016"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zfsRRabFVBUC", "citedby": "0"}, {"bib": {"title": "MTH1 Inhibitor-Induced Cytotoxicity in Acute Myeloid Leukemia", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Pqt4MY__2vwC", "citedby": "0"}, {"bib": {"title": "mTOR Dual Inhibitor Induced Cytotoxicity Depends on 4EBP1/c-Myc/Puma and NFkB/Egr-1/Bim Pathways in Human Lymphoid Malignancies", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9VeumLvkZSQC", "citedby": "0"}, {"bib": {"title": "Evaluation of DNA Repair Function as a Predictor of Response in a Clinical Trial of PARP Inhibitor Monotherapy for Recurrent Ovarian Carcinoma", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QtA78RmWg5MC", "citedby": "0"}, {"bib": {"title": "POPULATION PHARMACOKINETICS OF THE PARP INHIBITOR VELIPARIB IN WOMEN WITH OVARIAN CANCER: PI-094", "year": "2015"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NnTm98qLMbgC", "citedby": "0"}, {"bib": {"title": "Investigation of MLN4924 Alone and in Combination with Bcl-2 Inhibitors in Hematopoietic Stem Cells and Progenitors in Acute Myelogenous Leukemia", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:k8to_Y4Q4_EC", "citedby": "0"}, {"bib": {"title": "Using molecularly characterized patient-derived models to delineate underlying drivers and vulnerabilities of epithelial ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:UarirCmVI0EC", "citedby": "0"}, {"bib": {"title": "EXPLORATION OF RESISTANCE OF PARP INHIBITOR THERAPY IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED XENOGRAFTS.", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:kvJssbFybhEC", "citedby": "0"}, {"bib": {"title": "Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy-reaching beyond germline BRCA mutations", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ef2wPL15CskC", "citedby": "0"}, {"bib": {"title": "Abstract CT337: Phase I/Ib study of the PARP inhibitor (PARPi) olaparib (O) with carboplatin (C) in triple negative breast cancer (TNBC) at low genetic risk (NCT00647062)", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SgM-ki2adj0C", "citedby": "0"}, {"bib": {"title": "Preclinical evidence of a novel anti-tumor effect of met-formin in cholangiocarcinoma (CCA): 38", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qSd0DAb9jMoC", "citedby": "0"}, {"bib": {"title": "Abstract CT339: Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy-reaching beyond germline \u2026", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qCaWouos7ogC", "citedby": "0"}, {"bib": {"title": "Chk1 and WEE1 Inhibition Combine Synergistically and Represent a Novel Non-cytotoxic Combination in Acute Myeloid Leukemia", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:I2jIoRS3jIgC", "citedby": "0"}, {"bib": {"title": "O159 PDGF SENSITIZES CANCER-ASSOCIATED FIBROBLASTS TO APOPTOSIS IN A PUMA-DEPENDENT MANNER", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yCjxvIMm6_oC", "citedby": "0"}, {"bib": {"title": "PHASE I DOSE-ESCALATION AND DRUG INTERACTION STUDY OF ABT-888 (PARP1 INHIBITOR) AND TOPOTECAN (TOPOISOMERASE I INHIBITOR) IN PATIENTS WITH ADVANCED CANCER.: PI-003", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:koF6b02d8EEC", "citedby": "0"}, {"bib": {"title": "BCL2 Mutations Are Associated with Increased Risk of Transformation and Shortened Survival in Follicular Lymphoma", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wH03y5nBhxsC", "citedby": "0"}, {"bib": {"title": "In situ monitoring of the nascent Pseudomonas fluorescens biofilm response to variations in the dissolved organic carbon level in low-nutrient water by attenuated \u2026", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xm1hsP5ya-EC", "citedby": "0"}, {"bib": {"title": "Identification of a Novel Complex Required for WASH-dependent Receptor Trafficking", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:9CGX2owmTHMC", "citedby": "0"}, {"bib": {"title": "Kumiko Samejima1 $, Hiromi Ogawa1 $, Alexander V. Ageichik1^, Kevin L. Peterson2, Scott H.", "year": "2014"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oYwriLWYh5YC", "citedby": "0"}, {"bib": {"title": "Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:4tNoA7Af41QC", "citedby": "0"}, {"bib": {"title": "PDGF-BB Induces Apoptotic Priming of Cancer-Associated Fibroblasts in Cholangiocarcinoma: 1767", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RJujIP1NYNUC", "citedby": "0"}, {"bib": {"title": "Methods and materials for assessing enzyme-nucleic acid complexes", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:pxXbYLTb8EgC", "citedby": "0"}, {"bib": {"title": "Method of treating mantle cell lymphoma", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JdL-Xu2nR38C", "citedby": "0"}, {"bib": {"title": "Decreased 53BP1 expression predicts improved survival in sporadic ovarian carcinoma", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nroGzMJTTpEC", "citedby": "0"}, {"bib": {"title": "The role of CHFR expression in ovarian cancer and response to taxane therapy.", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:U3qCfcK-7lkC", "citedby": "0"}, {"bib": {"title": "Pharmacological inhibition of fatty acid synthase regulates BH3-only proteins and sensitizes breast cancer cells to a small molecule Bcl-2/Bcl-xL inhibitor to induce apoptosis.", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uWy0R8PweswC", "citedby": "0"}, {"bib": {"title": "Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: A study protocol for a double \u2026", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:bxPAEoiBajcC", "citedby": "0"}, {"bib": {"title": "A biotechnological approach to apoptosis of somatic and germ cells in living organisms.", "year": "2013"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_TjUWtciUekC", "citedby": "0"}, {"bib": {"title": "Targeting therapy based on preclinical analysis of clinical, molecular, and functional characteristics of individual high-grade serous ovarian cancers.", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3_f9JqYsqVQC", "citedby": "0"}, {"bib": {"title": "Loss of Hsulf-1 promotes chemoresistance and tumorigenecity in ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:09LM3QYkMKUC", "citedby": "0"}, {"bib": {"title": "A novel in vivo xenograft mouse model of human high-grade serous ovarian cancer, with clinical, molecular and functional annotation relevant for pre-clinical analysis", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:jq04SsiGh3QC", "citedby": "0"}, {"bib": {"title": "Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3.", "year": "2012"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yaBp1wUtcLsC", "citedby": "0"}, {"bib": {"title": "DEATH RECEPTOR 5 SIGNALING PROMOTES HEPATOCYTE LIPOAPOPTOSIS: 1686", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w9ZB08sdvuUC", "citedby": "0"}, {"bib": {"title": "Investigation of a potential pharmacokinetic interaction between ABT-888 and topotecan in a phase I trial", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SPgmg5JLkoEC", "citedby": "0"}, {"bib": {"title": "Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week oV schedule in patients with advanced solid tumors", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:djft3U1LymYC", "citedby": "0"}, {"bib": {"title": "Acute Myeloid Leukemia-Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:T_0gP6tLVL0C", "citedby": "0"}, {"bib": {"title": "Multi-institutional Phase II clinical and pharmacogenomic trial of tipifarnib", "year": "2011"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w0odbtu79TwC", "citedby": "0"}, {"bib": {"title": "OSI-027, a Dual TORC1/TORC2 Inhibitor, Induces Bim-and Puma-Mediated Apoptosis In Lymphoid Malignancy", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_AkkBXT-jcoC", "citedby": "0"}, {"bib": {"title": "Abstract A41: Somatic mutations in human cancer cell lines predict sorafenib response", "year": "2010"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yKzB5RS27GgC", "citedby": "0"}, {"bib": {"title": "Abstract A47: Somatic mutations in human cancer cell lines predict sorafenib response", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1Aeql8wG3wEC", "citedby": "0"}, {"bib": {"title": "Combinations of the Histone Deacetylase Inhibitor Entinostat (SNDX-275, MS-275) and Imatinib Have Divergent Effects in Imatinib-Sensitive Vs. Imatinib-Resistant p210-BCR/ABL \u2026", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:aCwMkEyfDy8C", "citedby": "0"}, {"bib": {"title": "The Nitric Acid Method for Protein Estimation in Biological Samples", "year": "2009"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:onKP9CxGSkIC", "citedby": "0"}, {"bib": {"title": "Identification of TCEAL7 as a regulator of c-Myc and neoplastic transformation", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KqW5X_olkfQC", "citedby": "0"}, {"bib": {"title": "Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo \u2026", "year": "2008"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GHsHDPAyICYC", "citedby": "0"}, {"bib": {"title": "In Vivo Correlates of Response for Phase I Trial of Oral Tipifarnib (T) Combined with Oral Etoposide (E) for Adults Age \u2265 70 with Newly Diagnosed Acute \u2026", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZYsTHYU9jrMC", "citedby": "0"}, {"bib": {"title": "Development of an immunocompetent mouse model of ovarian cancer", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:dhpJJ7xvgBgC", "citedby": "0"}, {"bib": {"title": "Trisomy 13 in patients with hematological malignancies", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:1wZ_wKGpLuwC", "citedby": "0"}, {"bib": {"title": "Apoptotic and anti-proliferative effects of the dual insulin-like growth factor-1 (IGF-1R)/insulin receptor inhibitor, BMS 536924, in acute myelogenous leukemia.", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:MqTxh1vmwXEC", "citedby": "0"}, {"bib": {"title": "Co-inhibition of the IGF-1R and HER family of receptors stimulates synergistic cell death in human ovarian cancer cells", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:I-2NeQpV75MC", "citedby": "0"}, {"bib": {"title": "BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:0urtJCGzaFQC", "citedby": "0"}, {"bib": {"title": "An optimization model of apoptosis: determination of kinetic constants", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yNlG6JgpFqoC", "citedby": "0"}, {"bib": {"title": "CLINICAL TRIALS AND OBSERVATIONS-A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous \u2026", "year": "2007"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PZE8UkGerEcC", "citedby": "0"}, {"bib": {"title": "GX15-070 SENSITIZES CHOLANGIOCARCINOMA CELLS TO TRAIL INDUCED APOPTOSIS BY RELEASING BAK FROM MCL-1: 125", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:J4E9jCG1tHUC", "citedby": "0"}, {"bib": {"title": "Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:bbjcffOLshcC", "citedby": "0"}, {"bib": {"title": "Vaccine adjuvants: Current state and future trends.", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3pYxbvHKFu8C", "citedby": "0"}, {"bib": {"title": "Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and-independent imatinib resistance. Commentary", "year": "2006"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5F1dSjz1ScoC", "citedby": "0"}, {"bib": {"title": "3 Approaches Used to Detect Apoptosis", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:s2G-WRnXBicC", "citedby": "0"}, {"bib": {"title": "JAK2 (V617F) Mutation Status and Neutrophil Apoptotic Resistance in Myelofibrosis with Myeloid Metaplasia (MMM): Correlation and Potential Identification through \u2026", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:GUYAmugLYisC", "citedby": "0"}, {"bib": {"title": "19. New Agents: 095 FINAL RESULTS OF A PHASE II TRIAL OF SINGLE-AGENT TEMSIROLIMUS (CCI-779) FOR RELAPSED MANTLE CELL LYMPHOMA", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KKBjqD86ppkC", "citedby": "0"}, {"bib": {"title": "BASIC\u2013LIVER, PANCREAS, AND BILIARY TRACT", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:SEKBqlyTJecC", "citedby": "0"}, {"bib": {"title": "The role of hyperthermia in potentiation of chemotherapy and radiotherapy in mice bearing solid tumor.", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:t9Ks5LMjN0QC", "citedby": "0"}, {"bib": {"title": "BASIC-LIVER, PANCREAS, AND BILIARY TRACT-Interleukin-6 Contributes to Mcl-1 Up-regulation and TRAIL Resistance via an Akt-Signaling Pathway in Cholangiocarcinoma Cells", "year": "2005"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Mx5hWS9ctUkC", "citedby": "0"}, {"bib": {"title": "Proteomic analysis of patients with mantle cell lymphoma identifies Hsp90, and other proteins as potential target (s) for drug therapy", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:FQ36aI_S1AEC", "citedby": "0"}, {"bib": {"title": "Ascorbic acid appears to increase the in vitro specificity and sensitivity of arsenic trioxide to the inhibition of primary myeloid colonies from patients with \u2026", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:KsTgnNRry18C", "citedby": "0"}, {"bib": {"title": "A candidate tumor suppressor HtrA1 down-regulated in ovarian cancer is a microtubule associated serine protease", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:xlVdBZVQT58C", "citedby": "0"}, {"bib": {"title": "Epigenetic silencing of a novel proapoptotic transcriptional regulatory protein in ovarian cancer", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:f2PrUAIjnKUC", "citedby": "0"}, {"bib": {"title": "Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. Vol. 278 (2003) 23107-23117", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oXKBmVzQOggC", "citedby": "0"}, {"bib": {"title": "ADDITIONS AND CORRECTIONS-Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. Vol. 278 (2003) 23107-23117.", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lOG7zRu2uA8C", "citedby": "0"}, {"bib": {"title": "Hopes for kinase inhibitors active against AML take FLT", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-fu4zM_6qcIC", "citedby": "0"}, {"bib": {"title": "GENOMICS, PROTEOMICS, AND BIOINFORMATICS-Genomic Mechanisms of p210BCR-ABL Signaling. INDUCTION OF HEAT SHOCK PROTEIN 70 THROUGH THE GATA RESPONSE ELEMENT CONFERS RESISTANCE TO \u2026", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Oj-SLI0tZTcC", "citedby": "0"}, {"bib": {"title": "CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits \u2026", "year": "2004"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Ul_CLA4dPeMC", "citedby": "0"}, {"bib": {"title": "Thromboembolism in adults with acute lymphoblastic leukemia (ALL) during induction with L-asparaginase (ASP)-containing multi-agent regimens: Incidence, risk factors, and \u2026", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qbqt7gslDFUC", "citedby": "0"}, {"bib": {"title": "Imatinib mesylate (STI-571), a c-Abl kinase inhibitor, indirectly blocks receptor tyrosine kinase activation and induces apoptosis in a human cholangiocarcinoma cell line", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JIEWM9yDoCIC", "citedby": "0"}, {"bib": {"title": "DNA-tethered membranes formed by giant vesicle rupture.", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mS4qin7VKjkC", "citedby": "0"}, {"bib": {"title": "MOLECULAR TARGETS FOR THERAPY (MTT)", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:654Jc7Ppz2kC", "citedby": "0"}, {"bib": {"title": "CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid \u2026", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:_n8fIOMweQoC", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 \u2026", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZqLB7dQ1iF4C", "citedby": "0"}, {"bib": {"title": "Alterations in the apoptotic machinery and their potential role in anticancer drug resistance", "year": "2003"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TiIbgCYny7sC", "citedby": "0"}, {"bib": {"title": "Bcl-2 over-expression results in decreased measles virus mediated cytotoxicity in lymphoma cell lines.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:WM2K3OHRCGMC", "citedby": "0"}, {"bib": {"title": "Imatinib messilate induces apoptosis in a cholangiocarcinoma cell line.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:rJyh6hJnyfgC", "citedby": "0"}, {"bib": {"title": "Bile acids induce cyclooxygenase-2 expression via stimulation of the epidermal growth factor receptor in a human cholangiocarcinoma cell line", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mgoTDWlsYNUC", "citedby": "0"}, {"bib": {"title": "in Biological Samples", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sfsSB7lKuh0C", "citedby": "0"}, {"bib": {"title": "MOLECULAR BASIS OF CELL AND DEVELOPMENTAL BIOLOGY-Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:zGWyAL6qfKUC", "citedby": "0"}, {"bib": {"title": "Practical Clinical Chemistry. Vol. 1. General Topics Commoner Test.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:V63Ir2N1OTwC", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated \u2026", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Lo8V22OuN40C", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Calpain-mediated X-linked Inhibitor of Apoptosis Degradation in Neutrophil Apoptosis and Its Impairment in Chronic Neutrophilic Leukemia.", "year": "2002"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uEM9VtRl8xsC", "citedby": "0"}, {"bib": {"title": "Sustained molecular remissions of acute promyelocytic leukemia (APL) following a single intensive course of consolidation chemotherapy.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Yw6v6SrDvuUC", "citedby": "0"}, {"bib": {"title": "Cell-cycle arrests and survival after topoisomerase I poisons are dependent on ATR kinase function.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:EsrhoZGmrkoC", "citedby": "0"}, {"bib": {"title": "Gerrero, M. Renee; Weber, Barbara L.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:IExZWSxeYXUC", "citedby": "0"}, {"bib": {"title": "Effects of the bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on leukemic cells in vitro.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-38epGy1wY0C", "citedby": "0"}, {"bib": {"title": "New insights in drug-induced cell death.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:LlXTz_FrCmAC", "citedby": "0"}, {"bib": {"title": "An aqueous Chlorella extract inhibits IL-5 production by mast cells in vitro and reduces ovalbumin-induced eosinophil infiltration in the airway in mice in vivo.", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JhbybO29vGQC", "citedby": "0"}, {"bib": {"title": "The role of caspases in Huntington's Disease", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eIKNFFVQvJAC", "citedby": "0"}, {"bib": {"title": "Box 1. Roles of caspases in apoptotic execution", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:RVqaWcrwK10C", "citedby": "0"}, {"bib": {"title": "Regular Articles-Experimental Therapeutics-The HER Tyrosine Kinase Inhibitor CI1033 Enhances Cytotoxicity of 7-Ethyl-10-hydroxycamptothecin and Topotecan by Inhibiting Breast \u2026", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:mJbmKSuM8toC", "citedby": "0"}, {"bib": {"title": "CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Clinical and biologic activity of the farnesyltransferase inhibitor RI15777 in adults with refractory and relapsed \u2026", "year": "2001"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:3x-KLxxGyuUC", "citedby": "0"}, {"bib": {"title": "Comparison of the action of NSC 680410 and STI571 in chronic myelogenous leukemia cells in vitro.", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:CMPXdcK5v8EC", "citedby": "0"}, {"bib": {"title": "Nitric oxide inhibits apoptosis downstream of cytochrome C release.", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:5bfplxN71z4C", "citedby": "0"}, {"bib": {"title": "Nitric oxide (NO) inhibits apoptosis in cholangiocarcinoma cells by blocking caspase 9 activation", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:QAOzB4mb83kC", "citedby": "0"}, {"bib": {"title": "Molecular Oncology, Markers, Clinical Correlates-Elevated Levels of p66 Shc Are Found in Breast Cancer Cell Lines and Primary Tumors with High Metastatic Potential", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qYOp8iumCsAC", "citedby": "0"}, {"bib": {"title": "Experimental Therapeutics, Preclinical Pharmacology-Methionine Depletion Enhances the Antitumoral Efficacy of Cytotoxic Agents in Drug-resistant Human Tumor Xenografts", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:lSLsV1MU4ZUC", "citedby": "0"}, {"bib": {"title": "Experimental Therapeutics, Preclinical Pharmacology-Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents", "year": "2000"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DPO9WFcz7UcC", "citedby": "0"}, {"bib": {"title": "Cathepsin B contributes to TNF-alpha/actinomycin D-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome C.", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:uPCvBZYD9qUC", "citedby": "0"}, {"bib": {"title": "CELL BIOLOGY AND METABOLISM-Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:-c_eYhz9dBkC", "citedby": "0"}, {"bib": {"title": "Xerophthalmia in Ethiopia: A nationwide ophthalmological, biochemical and anthropometric survey.", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:J-ba04ztB30C", "citedby": "0"}, {"bib": {"title": "CELL BIOLOGY AND METABOLISM-Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis", "year": "1999"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oFn-K-OQSCAC", "citedby": "0"}, {"bib": {"title": "Methods Used to Study Protease Activation During Apoptosis", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ON9TkA72AHEC", "citedby": "0"}, {"bib": {"title": "The search for cytotoxic synergy: An in vitro and clinical study of pyrazoloacridine (PZA) and carboplatin (CBDCA) in solid tumors.", "year": "1998"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ynsZFq2pu0MC", "citedby": "0"}, {"bib": {"title": "Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: Evidence for a protease-dependent pathway that does not activate cysteine protease 32 (vol 98 \u2026", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:o9ULDYDKYbIC", "citedby": "0"}, {"bib": {"title": "Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:JqN3CTdJtl0C", "citedby": "0"}, {"bib": {"title": "A unique cathepsin protease cascade contributes to apoptosis of Hep 3B cells by camptothecin.", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:sYWwZaPVD1oC", "citedby": "0"}, {"bib": {"title": "Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: A combined clinical and laboratory study (vol 23, pg 71, pg 1996)", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:g30IDTdgJMgC", "citedby": "0"}, {"bib": {"title": "Apoptotis: Pharmacological Implications and Therapeutic Opportunities. Advances in Pharmacology, Volume 41", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:qhW0HyKmSusC", "citedby": "0"}, {"bib": {"title": "Bedeutung der DNA-Topoisomerase I-Expression fuer die Sensitivitaet von Tumorzellen gegenueber Chemotherapeutika", "year": "1997"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gFrPXmx1TSsC", "citedby": "0"}, {"bib": {"title": "Cathepsin B protease activity but not interleukin 1 beta-converting enzyme (ICE) proteases contributes to camptothecin-induced apoptosis in a human hepatocellular carcinoma \u2026", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:PklR0melJeUC", "citedby": "0"}, {"bib": {"title": "Selective induction of apoptosis in a human hepatocellular carcinoma (HCC) cell line by the topoisomerase I inhibitor camptothecin.", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:oH8HCDhqVGsC", "citedby": "0"}, {"bib": {"title": "A suicide note from Alzheimer disease neurons?", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:TNEldfgDb5MC", "citedby": "0"}, {"bib": {"title": "PE \u3068 PVC \u306e\u6df7\u5408\u30d7\u30e9\u30b9\u30c1\u30c3\u30af\u304a\u3088\u3073 PE \u3068 PET \u306e\u6df7\u5408\u30d7\u30e9\u30b9\u30c1\u30c3\u30af\u306e\u71b1\u5206\u89e3\u6cb9\u5316", "year": "1996"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:nj26e0utjpAC", "citedby": "0"}, {"bib": {"title": "TOPOISOMERASE-I INHIBITORS INDUCE APOPTOSIS IN A HUMAN HEPATOCELLULAR-CARCINOMA (HCC) CELL-LINE BY A PROTEASE SENSITIVE PATHWAY", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:o-PowTg_VKEC", "citedby": "0"}, {"bib": {"title": "SPR biosensors: Historical perspectives and current challenges.", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:NKlx0PmyA3cC", "citedby": "0"}, {"bib": {"title": "La poly (ADP-ribose) polym\u00e9rase (PARP): \u00e0 la crois\u00e9e des chemins de la r\u00e9paration de l'ADN et de l'apoptose cellulaire.", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:v6PuF9mNY3oC", "citedby": "0"}, {"bib": {"title": "Poly (ADP-ribose) polymerase (PARP), at the crossroads of DNA repair and apoptosis", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:6pF0wJmtdfAC", "citedby": "0"}, {"bib": {"title": "SPECIFIC PROTEOLYTIC ACTIVITIES AS THE DRIVING-FORCE OF APOPTOTIC DEATH", "year": "1995"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:XeErXHja3Z8C", "citedby": "0"}, {"bib": {"title": "EXPRESSION OF THE HEMATOPOIETIC GROWTH-FACTOR RECEPTOR STK-1 (FLT3/FLK2), IN HUMAN ACUTE LEUKEMIAS", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:UKB2i6g6GNMC", "citedby": "0"}, {"bib": {"title": "TIMED SEQUENTIAL THERAPY (TST) FOR ACUTE MYELOCYTIC-LEUKEMIA (AML)-LONG-TERM FOLLOW-UP RESULTS", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tFzHCjejgA0C", "citedby": "0"}, {"bib": {"title": "Robert C. Moschel, S. Clifford Schold, Darell D. Bigner, and Francis Ali-Osman Departments of Pediatrics [HSFJ and Pathology [HSF, DDBJ, and the Preuss Laboratory for Brain \u2026", "year": "1994"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:j7XjBeKFbTsC", "citedby": "0"}, {"bib": {"title": "PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN (TPT), A-TOPOISOMERASE (TOPO) I-INHIBITOR, IN PATIENTS (PTS) WITH REFRACTORY LEUKEMIAS", "year": "1993"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:hB2aVRuWZNwC", "citedby": "0"}, {"bib": {"title": "Expression of poly (ADP-ribose) polymerase in differentiating HL-60 cells", "year": "1992"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:w7CBUyPWg-0C", "citedby": "0"}, {"bib": {"title": "Omega-3 fatty acids: A comprehensive review of their role in health and disease.", "year": "1991"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:gL9scSG3K_gC", "citedby": "0"}, {"bib": {"title": "Rocket Photometry and the Lower-Thermospheric Oxygen Nightglow: Discussion", "year": "1987"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:E2bRg1zSkIsC", "citedby": "0"}, {"bib": {"title": "The mechanism of the oxygen airglow", "year": "1987"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:8O4vDxvErlEC", "citedby": "0"}, {"bib": {"title": "Right ventricular infarction complicated by right to left shunt: III", "year": "1983"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:43LB_KcVqeAC", "citedby": "0"}, {"bib": {"title": "A DISTINCT CLASS OF NON-HISTONE NUCLEAR PROTEINS INCLUDING NUCLEOLAR PROTEIN-B23 ARE RENDERED NUCLEASE-RESISTANT AND SALT-RESISTANT BY THE SULFHYDRYL CROSSLINKING REAGENT \u2026", "year": "1982"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:YGhAHpnIhDoC", "citedby": "0"}, {"bib": {"title": "A new method for quantitating nuclear transfer of glucocorticoid receptor complexes in leukemic cells", "year": "1982"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:j2GSQqY3pL0C", "citedby": "0"}, {"bib": {"title": "Induction of hyperphagia in rats by intracerebroventricular infusion of sodium pentobarbital. A method for testing anorexigenic compounds.", "year": "1981"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:ZpgFv6i7Z4gC", "citedby": "0"}, {"bib": {"title": "The Clinical Investigator as an Endangered Species", "year": "1980"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:eLRq4zTgah0C", "citedby": "0"}, {"bib": {"title": "Prenatal evaluation of hormone receptor interactions", "year": "1976"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Q3-QASNKTMEC", "citedby": "0"}, {"bib": {"title": "Current Concepts and Unanswered Questions", "year": "1966"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:URGbnSt0D2cC", "citedby": "0"}, {"bib": {"title": "Editorial board\u2022 EDITORIAL BOARD"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:q7LczdTNAjsC", "citedby": "0"}, {"bib": {"title": "MTH1 inhibitors to cisplatin resistant cell"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:yL7DKRohVA8C", "citedby": "0"}, {"bib": {"title": "Phase II Trial of STI571 in Myelofibrosis with Myeloid Metaplasia"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:tfDI-GPdlUQC", "citedby": "0"}, {"bib": {"title": "Human Lung Carcinoma Cells'"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:iWL_APfBKHwC", "citedby": "0"}, {"bib": {"title": "11 Targeting the Apoptotic Machinery as"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:Dmoar05iI2YC", "citedby": "0"}, {"bib": {"title": "JCB: Correction"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:bkKuixW_xMkC", "citedby": "0"}, {"bib": {"title": "Development of PARP Inhibitors: An Unfinished Story The Comen/Robson Article Reviewed [READ ARTICLE]"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:cx97FdCJQX8C", "citedby": "0"}, {"bib": {"title": "The Farnesyltransferase Inhibitor Zarnestra is well tolerated, induces"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:wlzmIqt2EaEC", "citedby": "0"}, {"bib": {"title": "Active oral regimen for elderly adults with newly diagnosed acute"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:DUFsPKDdMi0C", "citedby": "0"}, {"bib": {"title": "Adaphostin-induced apoptosis in CLL B-cells is associated with induction"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:37Fl7vPTsUIC", "citedby": "0"}, {"bib": {"title": "ARIEL2 and ARIEL3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:s1ouQE5r0WUC", "citedby": "0"}, {"bib": {"title": "For any communications regarding this protocol, please call the protocol resource person on the following page."}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:vofGIMt6cyEC", "citedby": "0"}, {"bib": {"title": "CHAPrER 25 Erasable Western Blots"}, "source": "citations", "id_citations": "BuPwbcQAAAAJ:IyxfXMz2bNAC", "citedby": "0"}]}